Audicus Omni 2 vs JLab Hear OTC

The Audicus Omni 2 is a premium-priced behind-the-ear OTC hearing aid available for $1,898. With a SoundScore of 4.6/5 and an A grade, it ranks #5 among 65 OTC hearing aids tested, placing it in the top 6% of its category. In our lab testing, the Omni 2 demonstrates strong speech clarity in quiet environments, scoring 4.2/5—well above the category average by 1.38 points. Speech in noise performance is more modest at 2.3/5, which is above the category average by 0.79 points but mixed in absolute terms. This pattern suggests the device handles everyday conversations well while challenging listening situations may still present difficulty. Music streaming is a particular strength, scoring 3.6/5 and exceeding the category average by a substantial 1.68 points. Feedback handling is excellent at 4.5/5, virtually matching the category average. Own-voice comfort scores a solid 3.0/5, which is 0.49 points above average for OTC devices. The Omni 2 offers both rechargeable and disposable battery options, along with streaming compatibility for iPhone and Android devices with hands-free capability. It has earned Expert's Choice Awards for both 2023 and 2024. Consumers seeking alternatives in this price range may also consider the similarly-priced Lucid Tala, while the lower-priced Lexie B3 offers competitive performance for those with tighter budgets.

The JLab Hear OTC is a budget-priced OTC hearing aid released in 2024, earning a B grade with a SoundScore of 3.5/5 in our lab testing. At $100, it represents one of the most affordable entry points into the OTC hearing aid market, ranking #36 of 65 devices in its category. This visible-in-ear device delivers a distinctive performance profile with clear strengths and weaknesses. Its standout feature is excellent music streaming quality, scoring 4.6/5—a remarkable 2.68 points above the category average. Feedback handling is equally impressive at 5.0/5, meaning users can expect stable performance without whistling during daily activities. These results suggest JLab leveraged its audio expertise from consumer earbuds in developing this product. However, speech clarity presents challenges. Speech in quiet scored 2.1/5 (0.67 points below category average), while speech in noise scored 1.0/5 (0.46 points below average). Own-voice comfort also measured low at 1.8/5. These limitations are significant for users prioritizing conversation clarity, which is typically the primary reason people seek hearing aids. The JLab Hear OTC is best suited for budget-conscious consumers who value music and media streaming alongside basic amplification, rather than those needing maximum speech intelligibility. Features include rechargeable batteries, iPhone and Android streaming, and hands-free functionality. Buyers seeking stronger speech performance in this price range may want to compare options like the higher-scoring Elehear Beyond or Apple AirPods Pro 2.